Recombinant Yersinia pseudotuberculosis serotype O:3 Ferrochelatase (hemH)

What is ferrochelatase (hemH) and its functional significance in Y. pseudotuberculosis?

Ferrochelatase (EC 4.99.1.1), encoded by the hemH gene, catalyzes the final step in the heme biosynthetic pathway by inserting ferrous iron (Fe²⁺) into protoporphyrin IX to form heme. In bacterial pathogens, this enzyme plays a crucial role in energy metabolism and virulence.

While Y. pseudotuberculosis hasn't been specifically characterized in the provided literature, studies in other bacterial pathogens like Haemophilus influenzae demonstrate that ferrochelatase activity allows bacteria to utilize protoporphyrin IX when exogenous iron is available . This ability to synthesize heme from available precursors likely contributes to Y. pseudotuberculosis adaptability in different host environments where iron availability varies.

In research contexts, it's important to recognize that Y. pseudotuberculosis serotype O:1b strains show variation in virulence determinants , suggesting potential differences in metabolic pathways that might affect hemH expression or function across serotypes, including the O:3 serotype of interest.

How does growth medium composition affect recombinant hemH expression and activity?

Growth medium composition critically influences recombinant protein expression levels and enzymatic activity. Based on studies with other bacterial ferrochelatases, researchers should consider:

• Supplementation with iron sources: Ferrous iron availability directly affects ferrochelatase activity and potentially its expression regulation

• Protoporphyrin IX availability: As the substrate for ferrochelatase, its presence in the medium can affect enzyme expression

• Hemin supplementation: May downregulate native hemH expression through feedback mechanisms

A systematic approach to medium optimization should be employed. For example, in H. influenzae studies, the following growth phenotypes were observed under different supplementation conditions:

This table demonstrates that while wild-type strains can utilize both hemin and protoporphyrin IX (PPIX) for growth, hemH mutants can only utilize hemin, confirming ferrochelatase's role in PPIX utilization . Similar experimental designs could elucidate Y. pseudotuberculosis hemH function.

What expression systems are recommended for producing recombinant Y. pseudotuberculosis hemH?

For successful expression of recombinant Y. pseudotuberculosis hemH, an E. coli-based expression system using IPTG-inducible T7 RNA polymerase has proven effective for other bacterial ferrochelatases . This approach offers several advantages:

• High protein yields are achievable (up to 250 mg/L of soluble protein has been reported for other recombinant proteins)

• Ease of genetic manipulation and transformation

• Rapid growth at high cell density with relatively inexpensive substrates

• Well-established protocols for induction and harvesting

A recommended expression protocol based on successful ferrochelatase studies includes:

• Transformation of E. coli BL21(DE3) with the hemH-containing plasmid

• Culture in LB medium supplemented with appropriate antibiotics

• Growth at 30°C (rather than 37°C) to enhance soluble protein expression

• Induction with IPTG at OD₆₀₀ of 0.25-0.3

• Expression for 4 hours post-induction

• Cell harvesting by centrifugation followed by washing with Tris-HCl buffer

• Cell lysis using lysozyme treatment (0.25 mg/ml) followed by sonication

It's important to note that expression conditions should be optimized specifically for Y. pseudotuberculosis hemH, as optimal conditions vary between recombinant proteins and systems.

What purification strategies are effective for recombinant hemH?

Purification of recombinant ferrochelatase requires strategies that maintain protein structure and enzymatic activity. Based on successful purification of B. subtilis ferrochelatase, researchers should consider:

• Initial clarification of cell lysate by centrifugation (10,000 × g at 4°C)

• Column chromatography approaches following established protocols for bacterial ferrochelatases

• Buffer systems maintaining pH 7.4 (typically 50 mM Tris-HCl)

• Inclusion of reducing agents to maintain cysteine residues in reduced form

• Storage conditions that prevent protein oxidation and denaturation

The purification methodology developed by Hansson and Al-Karadaghi has proven effective for bacterial ferrochelatases and could be adapted for Y. pseudotuberculosis hemH with appropriate optimization.

How can site-directed mutagenesis be used to study conserved residues in Y. pseudotuberculosis hemH?

Site-directed mutagenesis provides powerful insights into structure-function relationships of ferrochelatase. Based on studies with B. subtilis ferrochelatase, researchers should:

• Identify conserved residues through sequence alignment of Y. pseudotuberculosis hemH with other bacterial ferrochelatases

• Design mutagenesis primers targeting specific residues (studies on B. subtilis identified S54 and Q63 as functionally important conserved residues)

• Construct plasmids carrying the mutated hemH gene

• Verify mutations through DNA sequencing of both strands

• Express both wild-type and mutant proteins for comparative analysis

• Perform both in vitro activity assays and in vivo complementation studies

The approach used for B. subtilis involved:

• Creating alanine substitutions at conserved residues

• Using oligonucleotide primers designed specifically for each mutation

• Confirming mutations by DNA sequencing

• Expressing mutant proteins in E. coli

• Analyzing growth phenotypes and enzyme kinetics

This methodology revealed that certain conserved residues (like S54 in B. subtilis) may have different functional impacts in vivo versus in vitro, highlighting the importance of comprehensive analysis.

What explains the discrepancies between in vivo and in vitro hemH activity studies?

A critical finding from bacterial ferrochelatase research is the significant discrepancy between in vivo and in vitro activities. For B. subtilis ferrochelatase:

• In vivo turnover was calculated at approximately 0.2 min⁻¹

• In vitro turnover was measured at 24-28 min⁻¹, representing a 100-fold difference

This discrepancy has profound implications for Y. pseudotuberculosis hemH research:

• The standard in vitro assay using Zn²⁺ and protoporphyrin IX solubilized in Tween 80 creates highly artificial conditions that may not reflect physiological reality

• Mutations that show minimal effect in vitro may significantly impact in vivo function

• In vivo, ferrochelatase likely functions within a substrate channeling complex with other proteins

For example, the B. subtilis S54A mutation had no effect on in vitro activity but caused slower growth and coproporphyrin accumulation in vivo, suggesting this residue may be involved in protein-protein interactions rather than catalysis . This highlights the importance of combining both in vitro biochemical and in vivo physiological studies when characterizing Y. pseudotuberculosis hemH.

How should experimental design approaches be applied to optimize recombinant Y. pseudotuberculosis hemH expression?

Multivariate statistical approaches are strongly recommended for optimizing recombinant protein expression. Rather than traditional one-factor-at-a-time methods, factorial designs allow researchers to:

• Identify statistically significant variables affecting expression

• Determine optimal culture conditions with fewer experiments

• Detect interactions between variables that single-factor approaches would miss

• Characterize experimental error systematically

• Compare the effects of normalized variables quantitatively

Key variables to consider in a factorial design for hemH expression include:

• Induction timing (cell density at induction)

• Inducer concentration

• Post-induction temperature

• Growth medium composition

• Expression duration

• Dissolved oxygen levels

This approach has been successfully used to achieve high-level soluble expression (250 mg/L) of recombinant proteins in E. coli and could be adapted for Y. pseudotuberculosis hemH expression optimization.

How can researchers investigate potential hemH involvement in substrate channeling?

The phenomenon of substrate channeling—where metabolic intermediates are directly transferred between enzymes without release into the bulk solvent—appears relevant to ferrochelatase function. Evidence from B. subtilis suggests:

• Conserved surface residues like S54 may function as docking sites for protein-protein interactions

• These interactions could facilitate delivery of protoporphyrin IX, Fe²⁺, or retrieval of the heme product

• Disruption of these interactions causes metabolic bottlenecks leading to precursor accumulation

To investigate substrate channeling involving Y. pseudotuberculosis hemH, researchers should:

• Identify potential interaction partners through computational analysis and pull-down assays

• Perform surface residue mutations followed by growth studies and metabolite analysis

• Conduct co-immunoprecipitation experiments to verify protein-protein interactions

• Utilize proximity labeling techniques to map the immediate environment of hemH in vivo

• Analyze porphyrin accumulation patterns in wild-type versus mutant strains

The observation that iron-deficient B. subtilis accumulates coproporphyrin suggests that substrate availability and channeling efficiency are interconnected, providing an experimental avenue to explore this phenomenon in Y. pseudotuberculosis.

What role might hemH play in Y. pseudotuberculosis virulence based on studies in other pathogens?

While direct evidence for hemH's role in Y. pseudotuberculosis virulence is lacking in the provided literature, studies in H. influenzae provide valuable insights:

• H. influenzae hemH mutants showed no difference in bacteremia levels compared to wild-type when tested in infant rats (2.78 × 10⁶ ± 1.9 × 10⁶ CFU/ml for wild-type versus 2.98 × 10⁶ ± 2.1 × 10⁶ CFU/ml for hemH mutant)

• Both wild-type and hemH mutant strains had similar virulence, causing death by 72 hours post-infection

• No difference in nasopharyngeal colonization was observed between wild-type and hemH mutant strains

• Survival under iron-limited conditions reminiscent of host environments

• Growth in serum or whole blood

• Resistance to host defense mechanisms

• Animal infection models specific to Y. pseudotuberculosis pathogenesis

• Interactions with Y. pseudotuberculosis-specific virulence determinants like pVM82, HPI, YAPI, and YPM

What assays are recommended for measuring Y. pseudotuberculosis hemH activity?

Based on established protocols for bacterial ferrochelatases, the following assays are recommended:

• In vitro enzyme activity assay:

  • Uses zinc (Zn²⁺) as a substitute for iron due to technical advantages

  • Protoporphyrin IX solubilized in Tween 80 as substrate

  • Spectrofluorometric measurement of zinc-protoporphyrin formation

  • Calculation of kinetic parameters (Km and Vmax) under varying substrate concentrations

• In vivo complementation assays:

  • Construction of hemH mutants of Y. pseudotuberculosis

  • Growth assessment with different porphyrin and iron sources

  • Measurement of porphyrin accumulation

  • Genetic complementation with wild-type or mutant hemH alleles

• Porphyrin accumulation analysis:

  • Extraction of porphyrins from bacterial cultures

  • HPLC separation and quantification

  • Fluorescence spectroscopy for identification

Researchers should note that the standard in vitro assay creates artificial conditions that may not reflect physiological reality , emphasizing the importance of complementary in vivo approaches.

How should researchers interpret contradictory results between different experimental systems?

The research on bacterial ferrochelatases reveals important lessons about interpreting contradictory results:

How can CRISPR-Cas systems be used to study hemH in Y. pseudotuberculosis?

Y. pseudotuberculosis strains contain CRISPR-Cas loci that can be leveraged for genetic manipulation. The search results indicate that 86% of Y. pseudotuberculosis strains include three CRISPR loci: YP1, YP2, and YP3 . Researchers can:

• Utilize native CRISPR-Cas systems for targeted genome editing:

  • Design guide RNAs targeting hemH

  • Introduce specific mutations or deletions

  • Create marker-less genetic modifications

• Study potential interactions between CRISPR-Cas systems and horizontal gene transfer:

  • CRISPR-Cas functions as an adaptive protection system against mobile genetic elements

  • This may influence horizontal transfer of genes potentially interacting with hemH

  • The length of CRISPR locus YP3 depends on the presence of virulence determinants in Y. pseudotuberculosis serotype O:1b strains

• Investigate potential regulatory links between CRISPR-Cas and metabolic pathways including heme biosynthesis

This approach allows for precise genetic manipulation without introducing antibiotic resistance markers, potentially providing cleaner systems for studying hemH function.

What structural biology approaches would advance understanding of Y. pseudotuberculosis hemH?

Structural studies of Y. pseudotuberculosis hemH would provide valuable insights into its function and potential inhibitor design. Recommended approaches include:

• X-ray crystallography of:

  • Wild-type hemH in various liganded states

  • hemH in complex with substrate or product

  • hemH with site-directed mutations at conserved residues

• Cryo-electron microscopy to:

  • Visualize potential larger complexes involving hemH

  • Study dynamic conformational changes during catalysis

• Molecular dynamics simulations to:

  • Model substrate binding and product release

  • Explore conformational flexibility

  • Predict effects of specific mutations

The structural insights from other bacterial ferrochelatases, particularly the identification of conserved surface residues potentially involved in protein-protein interactions , provide a foundation for these studies.

How might systems biology approaches integrate hemH into broader metabolic networks?

Systems biology approaches would position hemH within the broader context of Y. pseudotuberculosis metabolism and virulence:

These approaches would help position hemH within Y. pseudotuberculosis's complex adaptive strategies during infection and environmental stress.

What are the implications of hemH research for developing new antimicrobial strategies?

Research on Y. pseudotuberculosis hemH has potential implications for antimicrobial development:

• Targeting hemH directly:

  • While hemH mutations in H. influenzae did not affect virulence in animal models , species-specific differences may exist

  • Inhibitors could be designed based on structural studies

  • Combination approaches targeting multiple steps in heme acquisition could be effective

• Disrupting protein-protein interactions:

  • If hemH participates in substrate channeling complexes, these interfaces represent potential targets

  • The conserved S54 residue identified in B. subtilis as a potential docking site offers a starting point

• Exploiting iron metabolism vulnerabilities:

  • Creating artificial iron limitation while simultaneously inhibiting hemH could create metabolic stress

  • Inducing toxic accumulation of porphyrin intermediates through selective pathway inhibition

• Developing strain-specific approaches:

  • Different Y. pseudotuberculosis serotypes may have variations in heme metabolism

  • Virulence determinant profiles correlate with CRISPR-loci patterns , suggesting potential metabolic differences to exploit